4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-21-046365
Chairman and CEO bought 4,000 shares at an average $1.54 ($6,150)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2021-07-08 | Purchase | +2,000 | $1.54 | $3,080 | 10,785,571 | D: show line 1 in the form |
| Niihara Yutaka Chairman and CEO | 2021-07-09 | Purchase | +1,000 | $1.54 | $1,540 | 10,786,571 | D: show line 2 in the form |
| Niihara Yutaka Chairman and CEO | 2021-07-12 | Purchase | +1,000 | $1.53 | $1,530 | 10,787,571 | D: show line 3 in the form |
| Open-market purchases · 4,000 sh · avg $1.54 · $6,150 | |||||||
Loading xslF345X03/doc4.xml…